Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigation and treatment of pulmonary embolism as a potential etiology may be important to improve post-resuscitation prognosis in non-shockable out-of-hospital cardiopulmonary arrest: report on an analysis of the SOS-KANTO 2012 study.
SOS‐KANTO 2012 Study Group; Inokuchi S, Masui Y, Miura K, Tsutsumi H, Takuma K, Atsushi I, Nakano M, Tanaka H, Ikegami K, Arai T, Yaguchi A, Kitamura N, Oda S, Kobayashi K, Suda T, Ono K, Morimura N, Furuya R, Koido Y, Iwase F, Nagao K, Kanesaka S, Okada Y, Unemoto K, Sadahiro T, Iyanaga M, Muraoka A, Hayashi M, Ishimatsu S, Miyake Y, Yokokawa H, Koyama Y, Tsuchiya A, Kashiyama T, Hayashi M, Oshima K, Kiyota K, Hamabe Y, Yokota H, Hori S, Inaba S, Sakamoto T, Harada N, Kimura A, Kanai M, Otomo Y, Sugita M, Kinoshita K, Sakurai T, Kitano M, Matsuda K, Tanaka K, Yoshihara K, Yoh K, Suzuki J, Toyoda H, Mashiko K, Shimizu N, Muguruma T, Shimada T, Kobe Y, Shoko T, Nakanishi K, Shiga T, Yamamoto T, Sekine K, Izuka S. SOS‐KANTO 2012 Study Group, et al. Among authors: yoh k. Acute Med Surg. 2016 Mar 11;3(3):250-259. doi: 10.1002/ams2.183. eCollection 2016 Jul. Acute Med Surg. 2016. PMID: 29123793 Free PMC article.
Neutrophil elastase and systemic inflammatory response syndrome in the initiation and development of acute lung injury among critically ill patients.
Fujishima S, Morisaki H, Ishizaka A, Kotake Y, Miyaki M, Yoh K, Sekine K, Sasaki J, Tasaka S, Hasegawa N, Kawai Y, Takeda J, Aikawa N. Fujishima S, et al. Among authors: yoh k. Biomed Pharmacother. 2008 Jun;62(5):333-8. doi: 10.1016/j.biopha.2007.07.003. Epub 2007 Jul 31. Biomed Pharmacother. 2008. PMID: 17698318
RELAY: Final Overall Survival for Erlotinib + Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC.
Nakagawa K, Garon EB, Seto T, Nishio M, Aix SP, Paz-Ares L, Chiu CH, Park K, Novello S, Nadal E, Nishino K, Yoh K, Shih JY, Chik JY, Moro-Sibilot D, Puri T, Varughese SC, Frimodt-Moller B, Visseren-Grul C, Reck M. Nakagawa K, et al. Among authors: yoh k. J Thorac Oncol. 2024 Nov 30:S1556-0864(24)02495-X. doi: 10.1016/j.jtho.2024.11.032. Online ahead of print. J Thorac Oncol. 2024. PMID: 39622410
Difference in efficacy of osimertinib between patients with EGFR-positive NSCLC with postoperative recurrence and those with de novo unresectable disease: A prospective, observational study.
Karayama M, Suda T, Yoh K, Usui K, Hosomi Y, Kishi K, Naka G, Watanabe K, Tamano S, Uemura K, Kunitoh H. Karayama M, et al. Among authors: yoh k. Lung Cancer. 2024 Nov 26;198:108037. doi: 10.1016/j.lungcan.2024.108037. Online ahead of print. Lung Cancer. 2024. PMID: 39602849
Transverse versus vertical incision in the surgical management of placenta accreta spectrum.
Oberlin A, Yoh K, Overton E, Booker WA, Ilagan J, Sassine D, Diggs A, Laifer-Narin S, Cimic A, Ring L, Sheikh M, St Clair C, Hou J, Buckley de Meritens A, Wright JD, D'Alton M, Nhan Chang CL, Mourad M, Khoury Collado F. Oberlin A, et al. Among authors: yoh k. Am J Perinatol. 2024 Nov 20. doi: 10.1055/a-2479-2604. Online ahead of print. Am J Perinatol. 2024. PMID: 39566520
NETosis in pulmonary pleomorphic carcinoma.
Oi H, Taki T, Kuroe T, Sakamoto N, Sakashita S, Kojima M, Sugiyama E, Umemura S, Sakai T, Izumi H, Zenke Y, Matsumoto S, Yoh K, Ishii M, Tsuboi M, Goto K, Ishii G. Oi H, et al. Among authors: yoh k. Cancer Sci. 2024 Nov 18. doi: 10.1111/cas.16332. Online ahead of print. Cancer Sci. 2024. PMID: 39555736 Free article.
Efficacy, Safety, and Influence on Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1 Positive NSCLC: A Phase 2 Trial (EAST ENERGY).
Aokage K, Koyama S, Kumagai S, Nomura K, Shimada Y, Yoh K, Wakabayashi M, Fukutani M, Furuya H, Miyoshi T, Tane K, Samejima J, Taki T, Hayashi T, Matsubayashi J, Ishii G, Nishikawa H, Ikeda N, Tsuboi M. Aokage K, et al. Among authors: yoh k. Clin Cancer Res. 2024 Oct 25. doi: 10.1158/1078-0432.CCR-24-1561. Online ahead of print. Clin Cancer Res. 2024. PMID: 39453771
411 results